This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Oryzon Genomics S.a.. Active years: 2019-2026.
Company Filing History:
Years Active: 2019-2026
Title: Mark D. Demario: Innovator in Cancer Treatment
Introduction
Mark D. Demario is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic combinations.
Latest Patents
Mark D. Demario holds a patent for "Combinations of LSD1 inhibitors for use in the treatment of solid tumors." This invention relates to therapeutic combinations of LSD1 inhibitors and one or more other active pharmaceutical ingredients or pharmaceutically acceptable salts. The combinations are particularly useful for treating neoplastic diseases, such as cancer, with a focus on small cell lung cancer (SCLC).
Career Highlights
Mark is associated with Oryzon Genomics S.A., where he continues to advance his research in oncology. His work is pivotal in developing new treatment options for patients suffering from various forms of cancer.
Collaborations
Some of his notable coworkers include Tamara Maes and William E. Pierceall, who contribute to the collaborative efforts in research and development at Oryzon Genomics.
Conclusion
Mark D. Demario's innovative work in the field of cancer treatment exemplifies the impact of research and development in medicine. His contributions are vital for advancing therapeutic options for patients facing challenging diagnoses.